EQ
Equillium, Inc.
Price Chart
Latest Quote
$3.05
+0.06 (+2.01%)
Current Price
| Previous Close | $2.99 |
| Open | $3.02 |
| Day High | $3.12 |
| Day Low | $2.98 |
| Volume | 424,579 |
Stock Information
| Shares Outstanding | 63.23M |
| Total Debt | $692K |
| Cash Equivalents | $61.32M |
| Net Income | $-19.05M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $192.84M |
| EPS (TTM) | $-0.21 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $132.21M |
| Income | $-19.05M |
| Book/sh | $0.94 |
| Cash/sh | $0.97 |
| Employees | 14 |
Financial Ratios
| Quick Ratio | 18.33 |
| Current Ratio | 18.62 |
| Debt/Eq | 1.16 |
Returns & Margins
| ROA | -31.91% |
| ROE | -54.39% |
Ownership
| Insider Ownership | 16.05% |
| Institutional Ownership | 64.23% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -11.66 |
| P/B | 3.24 |
Analyst Data
| Recommendation | none |
| Target Price | $7.12 |
Technical Indicators
| SMA20 | $2.78 |
| SMA50 | $2.36 |
| SMA200 | $1.69 |
| RSI | 54.05 |
| ATR | 0.3600 |
| Shares Float | 33.56M |
| Short Float | 6.61% |
| Short Ratio | 9.24 |
| Volatility | 1.78 |
| Rel Volume | 0.36 |
Performance History
| Week | +8.54% |
| Month | +72.32% |
| Quarter | +42.52% |
| 6 Months | +152.07% |
| YTD | +99.35% |
| Year | +824.24% |
| 3 Years | +296.10% |
| 5 Years | -50.24% |
| 10 Years | -78.21% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $3.05 | 424,600 |
| 2026-06-17 | $2.99 | 699,600 |
| 2026-06-16 | $2.75 | 256,400 |
| 2026-06-15 | $2.80 | 362,100 |
| 2026-06-12 | $2.81 | 441,300 |
| 2026-06-11 | $2.81 | 554,700 |
| 2026-06-10 | $2.67 | 388,000 |
| 2026-06-09 | $2.70 | 436,300 |
| 2026-06-08 | $2.77 | 666,500 |
| 2026-06-05 | $2.94 | 1,143,900 |
| 2026-06-04 | $3.17 | 1,847,900 |
| 2026-06-03 | $3.11 | 3,700,600 |
| 2026-06-02 | $2.79 | 2,771,500 |
| 2026-06-01 | $3.08 | 5,176,300 |
| 2026-05-29 | $2.90 | 853,900 |
| 2026-05-28 | $2.84 | 1,903,000 |
| 2026-05-27 | $2.63 | 764,000 |
| 2026-05-26 | $2.32 | 269,900 |
| 2026-05-22 | $2.26 | 467,400 |
| 2026-05-21 | $2.21 | 275,800 |
| 2026-05-20 | $2.06 | 309,600 |
| 2026-05-19 | $1.77 | 214,500 |
About Equillium, Inc.
Equillium, Inc., a clinical-stage biotechnology company, develops therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders in the United States. The company develops EQ504, a novel AhR modulator that is in preclinical-stage for the treatment of ulcerative colitis and lung inflammation diseases. It also develops EQ302, a bi-specific inhibitor of IL-15 and IL-21 formulated for oral delivery for the treatment of celiac diseases. The company was formerly known as Attenuate Biopharmaceuticals, Inc. and changed its name to Equillium, Inc. in May 2017. Equillium, Inc. was incorporated in 2017 and is headquartered in La Jolla, California.
đ° Latest News
Analysts Grow More Confident In Equilliumâs (EQ) Lead Asset EQ504
Insider Monkey âĸ 2026-06-10T17:45:21Z
Equillium Links AhR Activation to miR-124 as EQ504 Heads Toward Phase 1
MarketBeat âĸ 2026-05-29T15:03:58Z
Hereâs What Roth Capital Thinks of Equillium (EQ) Stock
Insider Monkey âĸ 2026-03-24T21:38:39Z
Equillium Conference: EQ504 Targets Ulcerative Colitis Ahead of Mid-Year Phase 1 Start
MarketBeat âĸ 2026-02-13T18:28:36Z
Trending tickers: Intel, Tilray, monday.com, Equillium and AMC
Yahoo Finance UK âĸ 2025-08-12T08:44:10ZBC-Most Active Stocks
Associated Press Finance âĸ 2025-08-11T14:30:17ZSpotlight On 3 Promising Penny Stocks With Over $20M Market Cap
Simply Wall St. âĸ 2025-08-04T12:04:55Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $41,095,000 | $36,084,000 | $15,759,000 |
| Operating Revenue | $0 | $41,095,000 | $36,084,000 | $15,759,000 |
| Expenses | ||||
| Total Expenses | $23,634,000 | $49,364,000 | $50,606,000 | $54,786,000 |
| Other Income Expense | $403,000 | $-818,000 | $-76,000 | $-22,768,000 |
| Other Non Operating Income Expenses | $403,000 | $-818,000 | $-76,000 | $281,000 |
| Net Non Operating Interest Income Expense | $833,000 | $1,381,000 | $1,843,000 | $-633,000 |
| Operating Expense | $23,634,000 | $49,364,000 | $50,606,000 | $54,786,000 |
| General And Administrative Expense | $10,791,000 | $11,936,000 | $13,567,000 | $17,239,000 |
| Interest Expense | - | $0 | $491,000 | $1,053,000 |
| Interest Expense Non Operating | - | $0 | $491,000 | $1,053,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-22,398,000 | $-8,067,000 | $-13,335,000 | $-62,428,000 |
| Net Interest Income | $833,000 | $1,381,000 | $1,843,000 | $-633,000 |
| Interest Income | $833,000 | $1,381,000 | $2,334,000 | $420,000 |
| Normalized Income | $-22,398,000 | $-8,067,000 | $-13,335,000 | $-39,379,000 |
| Net Income From Continuing And Discontinued Operation | $-22,398,000 | $-8,067,000 | $-13,335,000 | $-62,428,000 |
| Total Operating Income As Reported | $-23,634,000 | $-8,269,000 | $-14,522,000 | $-62,076,000 |
| Net Income Common Stockholders | $-22,398,000 | $-8,067,000 | $-13,335,000 | $-62,428,000 |
| Net Income | $-22,398,000 | $-8,067,000 | $-13,335,000 | $-62,428,000 |
| Net Income Including Noncontrolling Interests | $-22,398,000 | $-8,067,000 | $-13,335,000 | $-62,428,000 |
| Net Income Continuous Operations | $-22,398,000 | $-8,067,000 | $-13,335,000 | $-62,428,000 |
| Pretax Income | $-22,398,000 | $-7,706,000 | $-12,755,000 | $-62,428,000 |
| Interest Income Non Operating | $833,000 | $1,381,000 | $2,334,000 | $420,000 |
| Operating Income | $-23,634,000 | $-8,269,000 | $-14,522,000 | $-39,027,000 |
| Special Income Charges | - | - | $0 | $-23,049,000 |
| Per Share | ||||
| Diluted EPS | $-0.39 | $-0.23 | $-0.38 | $-1.85 |
| Basic EPS | $-0.39 | $-0.23 | $-0.38 | $-1.85 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-23,518,000 | $-8,132,000 | $-12,138,000 | $-38,208,000 |
| Reconciled Depreciation | $116,000 | $137,000 | $126,000 | $118,000 |
| EBITDA (Bullshit earnings) | $-23,518,000 | $-8,132,000 | $-12,138,000 | $-61,257,000 |
| EBIT | $-23,634,000 | $-8,269,000 | $-12,264,000 | $-61,375,000 |
| Diluted Average Shares | $57,304,181 | $35,357,641 | $34,726,384 | $33,727,945 |
| Basic Average Shares | $57,304,181 | $35,357,641 | $34,726,384 | $33,727,945 |
| Diluted NI Availto Com Stockholders | $-22,398,000 | $-8,067,000 | $-13,335,000 | $-62,428,000 |
| Tax Provision | $0 | $361,000 | $580,000 | $0 |
| Research And Development | $12,843,000 | $37,428,000 | $37,039,000 | $37,547,000 |
| Selling General And Administration | $10,791,000 | $11,936,000 | $13,567,000 | $17,239,000 |
| Other Gand A | $10,791,000 | $11,936,000 | $13,567,000 | $17,239,000 |
| Total Unusual Items | - | - | $0 | $-23,049,000 |
| Total Unusual Items Excluding Goodwill | - | - | $0 | $-23,049,000 |
| Other Special Charges | - | - | - | $23,049,000 |
Fetched: 2026-06-15
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $28,597,000 | $19,061,000 | $22,573,000 | $31,942,000 |
| Total Assets | $31,887,000 | $25,604,000 | $50,530,000 | $78,421,000 |
| Total Non Current Assets | $849,000 | $626,000 | $1,181,000 | $1,686,000 |
| Other Non Current Assets | $27,000 | - | $70,000 | $104,000 |
| Current Assets | $31,038,000 | $24,978,000 | $49,349,000 | $76,735,000 |
| Other Current Assets | $214,000 | $429,000 | $235,000 | $8,000 |
| Prepaid Assets | $439,000 | $830,000 | $1,962,000 | $1,591,000 |
| Receivables | $108,000 | $1,144,000 | $6,286,000 | $4,113,000 |
| Other Receivables | $108,000 | $178,000 | $497,000 | $269,000 |
| Taxes Receivable | $0 | $966,000 | $2,054,000 | $1,006,000 |
| Cash Cash Equivalents And Short Term Investments | $30,277,000 | $22,575,000 | $40,866,000 | $71,023,000 |
| Cash And Cash Equivalents | $30,277,000 | $18,085,000 | $23,216,000 | $59,107,000 |
| Accounts Receivable | - | $0 | $3,735,000 | $2,838,000 |
| Debt | ||||
| Total Debt | $719,000 | $384,000 | $824,000 | $10,185,000 |
| Long Term Debt And Capital Lease Obligation | $356,000 | $187,000 | $384,000 | $4,063,000 |
| Current Debt And Capital Lease Obligation | $363,000 | $197,000 | $440,000 | $6,122,000 |
| Long Term Debt | - | - | - | $3,239,000 |
| Current Debt | - | - | - | $5,714,000 |
| Other Current Borrowings | - | - | - | $5,714,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $3,290,000 | $6,543,000 | $27,957,000 | $46,479,000 |
| Total Non Current Liabilities Net Minority Interest | $356,000 | $187,000 | $384,000 | $14,441,000 |
| Current Liabilities | $2,934,000 | $6,356,000 | $27,573,000 | $32,038,000 |
| Payables And Accrued Expenses | $2,571,000 | $6,159,000 | $11,404,000 | $11,216,000 |
| Payables | $755,000 | $3,041,000 | $4,707,000 | $3,977,000 |
| Total Tax Payable | $0 | $365,000 | $0 | - |
| Income Tax Payable | $0 | $365,000 | $0 | - |
| Accounts Payable | $755,000 | $2,676,000 | $4,707,000 | $3,977,000 |
| Current Deferred Liabilities | - | $0 | $15,729,000 | $14,700,000 |
| Non Current Deferred Liabilities | - | - | $0 | $10,378,000 |
| Interest Payable | - | - | $0 | $74,000 |
| Equity | ||||
| Common Stock Equity | $28,597,000 | $19,061,000 | $22,573,000 | $31,942,000 |
| Total Equity Gross Minority Interest | $28,597,000 | $19,061,000 | $22,573,000 | $31,942,000 |
| Stockholders Equity | $28,597,000 | $19,061,000 | $22,573,000 | $31,942,000 |
| Gains Losses Not Affecting Retained Earnings | $363,000 | $781,000 | $140,000 | $76,000 |
| Other Equity Adjustments | $363,000 | $781,000 | $140,000 | $76,000 |
| Retained Earnings | $-216,205,000 | $-193,807,000 | $-185,740,000 | $-172,405,000 |
| Other | ||||
| Ordinary Shares Number | $61,464,368 | $35,557,563 | $35,254,752 | $34,414,149 |
| Share Issued | $61,464,368 | $35,557,563 | $35,254,752 | $34,414,149 |
| Tangible Book Value | $28,597,000 | $19,061,000 | $22,573,000 | $31,942,000 |
| Invested Capital | $28,597,000 | $19,061,000 | $22,573,000 | $40,895,000 |
| Working Capital | $28,104,000 | $18,622,000 | $21,776,000 | $44,697,000 |
| Capital Lease Obligations | $719,000 | $384,000 | $824,000 | $1,232,000 |
| Total Capitalization | $28,597,000 | $19,061,000 | $22,573,000 | $35,181,000 |
| Additional Paid In Capital | $244,434,000 | $212,084,000 | $208,170,000 | $204,268,000 |
| Capital Stock | $5,000 | $3,000 | $3,000 | $3,000 |
| Common Stock | $5,000 | $3,000 | $3,000 | $3,000 |
| Long Term Capital Lease Obligation | $356,000 | $187,000 | $384,000 | $824,000 |
| Current Capital Lease Obligation | $363,000 | $197,000 | $440,000 | $408,000 |
| Current Accrued Expenses | $1,816,000 | $3,118,000 | $6,697,000 | $7,239,000 |
| Net PPE | $822,000 | $626,000 | $1,111,000 | $1,582,000 |
| Accumulated Depreciation | $-562,000 | $-499,000 | $-364,000 | $-249,000 |
| Gross PPE | $1,384,000 | $1,125,000 | $1,475,000 | $1,831,000 |
| Leases | $3,000 | $20,000 | $20,000 | $20,000 |
| Other Properties | $658,000 | $364,000 | $796,000 | $1,191,000 |
| Machinery Furniture Equipment | $723,000 | $741,000 | $659,000 | $620,000 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $0 | $4,490,000 | $17,650,000 | $11,916,000 |
| Current Deferred Revenue | - | $0 | $15,729,000 | $14,700,000 |
| Treasury Shares Number | - | - | $0 | - |
| Non Current Deferred Revenue | - | - | $0 | $10,378,000 |
Fetched: 2026-06-15
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-22,794,000 | $-19,111,000 | $-21,833,000 | $-9,012,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-22,746,000 | $-19,026,000 | $-21,783,000 | $-8,733,000 |
| Cash Flow From Continuing Operating Activities | $-22,746,000 | $-19,026,000 | $-21,783,000 | $-8,733,000 |
| Operating Gains Losses | $-455,000 | $794,000 | $58,000 | $260,000 |
| Investing Activities | ||||
| Capital Expenditure | $-48,000 | $-85,000 | $-50,000 | $-279,000 |
| Investing Cash Flow | $4,464,000 | $13,814,000 | $-4,762,000 | $18,684,000 |
| Cash Flow From Continuing Investing Activities | $4,464,000 | $13,814,000 | $-4,762,000 | $18,684,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $682,000 | $0 | - | $0 |
| Financing Cash Flow | $30,427,000 | $164,000 | $-9,228,000 | $-1,215,000 |
| Cash Flow From Continuing Financing Activities | $30,427,000 | $164,000 | $-9,228,000 | $-1,215,000 |
| Net Common Stock Issuance | $682,000 | $0 | $-260,000 | $0 |
| Common Stock Issuance | $682,000 | $0 | - | $0 |
| Repurchase Of Capital Stock | - | $0 | $-260,000 | $0 |
| Other | ||||
| End Cash Position | $30,277,000 | $18,085,000 | $23,216,000 | $59,107,000 |
| Beginning Cash Position | $18,085,000 | $23,216,000 | $59,107,000 | $50,366,000 |
| Effect Of Exchange Rate Changes | $47,000 | $-83,000 | $-118,000 | $5,000 |
| Changes In Cash | $12,145,000 | $-5,048,000 | $-35,773,000 | $8,736,000 |
| Proceeds From Stock Option Exercised | $29,745,000 | $164,000 | $165,000 | $214,000 |
| Net Investment Purchase And Sale | $4,500,000 | $13,899,000 | $-4,712,000 | $18,263,000 |
| Sale Of Investment | $4,500,000 | $31,500,000 | $50,000,000 | $33,225,000 |
| Purchase Of Investment | $0 | $-17,601,000 | $-54,712,000 | $-14,962,000 |
| Net PPE Purchase And Sale | $-36,000 | $-85,000 | $-50,000 | $-279,000 |
| Sale Of PPE | $12,000 | $0 | - | - |
| Purchase Of PPE | $-48,000 | $-85,000 | $-50,000 | $-279,000 |
| Change In Working Capital | $-2,317,000 | $842,000 | $-2,546,000 | $19,000 |
| Change In Other Working Capital | $42,000 | $-9,000 | $-13,000 | $75,000 |
| Change In Payables And Accrued Expense | $-3,622,000 | $-5,159,000 | $169,000 | $2,940,000 |
| Change In Accrued Expense | $-1,685,000 | $-3,164,000 | $-554,000 | $432,000 |
| Change In Payable | $-1,937,000 | $-1,995,000 | $723,000 | $2,508,000 |
| Change In Account Payable | $-1,937,000 | $-1,995,000 | $723,000 | $2,508,000 |
| Change In Prepaid Assets | $1,263,000 | $2,275,000 | $-1,805,000 | $-158,000 |
| Change In Receivables | $0 | $3,735,000 | $-897,000 | $-2,838,000 |
| Changes In Account Receivables | $0 | $3,735,000 | $-897,000 | $-2,838,000 |
| Stock Based Compensation | $2,322,000 | $3,750,000 | $3,997,000 | $4,841,000 |
| Amortization Of Securities | $-14,000 | $-754,000 | $-914,000 | $127,000 |
| Depreciation Amortization Depletion | $116,000 | $137,000 | $126,000 | $118,000 |
| Depreciation And Amortization | $116,000 | $137,000 | $126,000 | $118,000 |
| Depreciation | $116,000 | $137,000 | $126,000 | $118,000 |
| Net Foreign Currency Exchange Gain Loss | $-474,000 | $794,000 | $58,000 | $260,000 |
| Gain Loss On Sale Of PPE | $19,000 | $0 | - | - |
| Net Income From Continuing Operations | $-22,398,000 | $-8,067,000 | $-13,335,000 | $-62,428,000 |
| Repayment Of Debt | - | $0 | $-9,133,000 | $-1,429,000 |
| Interest Paid Supplemental Data | - | $0 | $946,000 | $847,000 |
| Income Tax Paid Supplemental Data | - | $0 | $580,000 | $0 |
| Common Stock Payments | - | $0 | $-260,000 | $0 |
| Net Issuance Payments Of Debt | - | $0 | $-9,133,000 | $-1,429,000 |
| Net Long Term Debt Issuance | - | $0 | $-9,133,000 | $-1,429,000 |
| Long Term Debt Payments | - | $0 | $-9,133,000 | $-1,429,000 |
| Other Non Cash Items | - | $-15,728,000 | $-9,169,000 | $48,330,000 |
| Net Business Purchase And Sale | - | - | $0 | $700,000 |
| Sale Of Business | - | - | $0 | $700,000 |
| Change In Other Current Liabilities | - | - | - | - |
| Change In Other Current Assets | - | - | - | - |
Fetched: 2026-06-15